Alpheus Medical
  • HOME
    • WHY WE DO IT
    • WHAT WE DO
    • HOW WE DO IT
  • HELP US COMBAT GBM
    • SONODYNAMIC BRAIN CANCER TRIAL
  • NEWS
  • ABOUT US
    • COMPANY OVERVIEW
    • LEADERSHIP
    • INVESTORS
Select Page

Alpheus Medical Announces Formation of World-Class Scientific Advisory Board

Mar 2, 2022

Alpheus Medical Announces Formation of World-Class Scientific Advisory Board (SAB) to Support Development of Novel Treatment for Brain Cancer SAB to provide meaningful guidance as the company begins a first-in-human (FIH) clinical trial of their proprietary,...

Alpheus Medical closes $16m in Series A financing for novel glioma brain cancer treatment

Nov 17, 2021

ALPHEUS MEDICAL CLOSES $16M IN SERIES A FINANCING FOR NOVEL GLIOMA BRAIN CANCER TREATMENT Funds to support first-in-human (FIH) clinical trial of the company’s proprietary, non-invasive sonodynamic drug-device therapy system for recurrent high-grade gliomas OAKDALE,...

RECENT NEWS

  • Alpheus Medical Announces Formation of World-Class Scientific Advisory Board March 2, 2022
  • Alpheus Medical closes $16m in Series A financing for novel glioma brain cancer treatment November 17, 2021

Designed by Elegant Themes | Powered by WordPress